Hematology NewsFirst-line obinutuzumab monotherapy in CLL linked to good response, reduced toxicityJuly 13, 2017CLLLeukemia, Myelodysplasia, Transplantation
Hematology TimesBlinatumomab granted full approval to treat rel/ref BCP-ALLJuly 13, 2017Leukemia, Myelodysplasia, TransplantationPharmacyALL
Hematology TimesODAC recommends approval of CTL019 in rel/ref ALLJuly 13, 2017Leukemia, Myelodysplasia, TransplantationPediatricsALL
Hematology TimesBenefits of gemtuzumab ozogamicin outweigh risks, ODAC saysJuly 13, 2017Leukemia, Myelodysplasia, TransplantationPharmacyAML
Hematology NewsAll FDA panel members go thumbs up for CTL019 in relapsed/refractory childhood ALLJuly 12, 2017ALLCellular TherapyLeukemia, Myelodysplasia, TransplantationImmuno-oncology
Hematology TimesFDA grants priority review to sNDA for dasatinibJuly 12, 2017Leukemia, Myelodysplasia, TransplantationPediatricsPharmacyCML
Hematology NewsFDA okays ClearLLab test for hematologic cancer detectionJuly 11, 2017Multiple MyelomaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMyelodysplastic Syndrome
Hematology NewsEnasidenib monotherapy responses in 37% with relapsed/refractory AML and IDH2 mutationsJuly 11, 2017AMLLeukemia, Myelodysplasia, Transplantation
Hematology TimesCommon insurance plans exclude NCI, NCCN cancer centersJuly 9, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaHematology Nursing
Hematology TimesMapping the genomic landscape of T-ALLJuly 6, 2017Leukemia, Myelodysplasia, TransplantationPediatricsALL
Hematology NewsNF-kB inhibitor IT-901 shows promise in Richter syndromeJuly 5, 2017CLLLeukemia, Myelodysplasia, Transplantation
Hematology NewsTelomere length predicts FCR response in CLL patientsJuly 5, 2017CLLLeukemia, Myelodysplasia, Transplantation
Hematology TimesEC approves therapy for relapsed/refractory BCP-ALLJuly 4, 2017Leukemia, Myelodysplasia, TransplantationPharmacyALL
Hematology TimesFDA clears use of reagents to detect hematopoietic neoplasiaJuly 3, 2017CythemiasAnemiaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaAggressive Lymphomas
Hematology TimesT-cell product improves outcomes of haplo-HSCTJune 29, 2017AnemiaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPediatricsTransplantation
